Ruicheng Yang, Lang Tian, Jundan Wang, Wenquan Ouyang, Huanchun Chen and Xiangru Wang*,
{"title":"Suilysin of Streptococcus suis Serotype 2 Drives Astrocyte Pyroptosis via Activation of the ROS/NLRP3/Caspase-1/GSDMD Pathway","authors":"Ruicheng Yang, Lang Tian, Jundan Wang, Wenquan Ouyang, Huanchun Chen and Xiangru Wang*, ","doi":"10.1021/acsinfecdis.6c00307","DOIUrl":null,"url":null,"abstract":"<p >Emerging evidence indicates that pyroptosis contributes to neuroinflammation and central nervous system (CNS) injuries. However, its role in <i>Streptococcus suis</i> (<i>S. suis</i>)-induced brain damage remains unclear. Here, we demonstrate that <i>S. suis</i> strain P1/7 infection triggers pyroptosis in astrocytes, specifically characterized by activating NLRP3/caspase-1/GSDMD axis. Suilysin (SLY), a key virulence factor of <i>S. suis</i>, dose- and time-dependently induced pyroptosis in U251 cells. Notably, genetic ablation of NLRP3 or GSDMD significantly attenuated SLY-induced pyroptosis, and caspase-1 inhibition similarly suppressed this process. Furthermore, SLY promoted reactive oxygen species (ROS) production, and scavenging ROS inhibited NLRP3/caspase-1/GSDMD activation and pyroptosis. Consistently, in a murine infection model, <i>S. suis</i> P1/7 induced astrocyte pyroptosis in brain tissues, while its sly deleted mutant (P1/7-Δ<i>sly</i>) significantly reduced this effect. These findings reveal that SLY mediates pyroptosis in astrocytes via the ROS/NLRP3/caspase-1/GSDMD pathway, highlighting its critical role in <i>S. suis</i>-induced neuropathogenesis.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 7","pages":"2345–2357"},"PeriodicalIF":4.5000,"publicationDate":"2026-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00307","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Emerging evidence indicates that pyroptosis contributes to neuroinflammation and central nervous system (CNS) injuries. However, its role in Streptococcus suis (S. suis)-induced brain damage remains unclear. Here, we demonstrate that S. suis strain P1/7 infection triggers pyroptosis in astrocytes, specifically characterized by activating NLRP3/caspase-1/GSDMD axis. Suilysin (SLY), a key virulence factor of S. suis, dose- and time-dependently induced pyroptosis in U251 cells. Notably, genetic ablation of NLRP3 or GSDMD significantly attenuated SLY-induced pyroptosis, and caspase-1 inhibition similarly suppressed this process. Furthermore, SLY promoted reactive oxygen species (ROS) production, and scavenging ROS inhibited NLRP3/caspase-1/GSDMD activation and pyroptosis. Consistently, in a murine infection model, S. suis P1/7 induced astrocyte pyroptosis in brain tissues, while its sly deleted mutant (P1/7-Δsly) significantly reduced this effect. These findings reveal that SLY mediates pyroptosis in astrocytes via the ROS/NLRP3/caspase-1/GSDMD pathway, highlighting its critical role in S. suis-induced neuropathogenesis.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.